These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1348 related articles for article (PubMed ID: 33558858)
1. Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis? Ramírez C; Herrera-Paz EF; Peralta G; Rodríguez G; Durón RM EClinicalMedicine; 2021 Feb; 32():100744. PubMed ID: 33558858 [No Abstract] [Full Text] [Related]
2. A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin. Hellwig MD; Maia A Int J Antimicrob Agents; 2021 Jan; 57(1):106248. PubMed ID: 33259913 [TBL] [Abstract][Full Text] [Related]
3. Oral ivermectin for the treatment and prophylaxis of scabies in prison. Ribeiro Fde A; Taciro E; Guerra MR; Eckley CA J Dermatolog Treat; 2005 Aug; 16(3):138-41. PubMed ID: 16096178 [TBL] [Abstract][Full Text] [Related]
4. Ivermectin distribution using community volunteers in Kabarole district, Uganda. Kipp W; Burnham G; Bamuhiiga J; Weis P; Büttner DW Health Policy Plan; 1998 Jun; 13(2):167-73. PubMed ID: 10180405 [TBL] [Abstract][Full Text] [Related]
5. Safety, Pharmacokinetics, and Activity of High-Dose Ivermectin and Chloroquine against the Liver Stage of Plasmodium cynomolgi Infection in Rhesus Macaques. Vanachayangkul P; Im-Erbsin R; Tungtaeng A; Kodchakorn C; Roth A; Adams J; Chaisatit C; Saingam P; Sciotti RJ; Reichard GA; Nolan CK; Pybus BS; Black CC; Lugo-Roman LA; Wegner MD; Smith PL; Wojnarski M; Vesely BA; Kobylinski KC Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660993 [TBL] [Abstract][Full Text] [Related]
6. Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Chaccour C; Rabinovich NR Malar J; 2017 Apr; 16(1):162. PubMed ID: 28434407 [TBL] [Abstract][Full Text] [Related]
7. Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing. Jermain B; Hanafin PO; Cao Y; Lifschitz A; Lanusse C; Rao GG J Pharm Sci; 2020 Dec; 109(12):3574-3578. PubMed ID: 32891630 [TBL] [Abstract][Full Text] [Related]
8. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection. de Castro CG; Gregianin LJ; Burger JA Leuk Lymphoma; 2020 Oct; 61(10):2536-2537. PubMed ID: 32611256 [No Abstract] [Full Text] [Related]
9. Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees. Taylor HR; Trpis M; Cupp EW; Brotman B; Newland HS; Soboslay PT; Greene BM Am J Trop Med Hyg; 1988 Jul; 39(1):86-90. PubMed ID: 3400802 [TBL] [Abstract][Full Text] [Related]
10. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. Choudhary R; Sharma AK New Microbes New Infect; 2020 May; 35():100684. PubMed ID: 32322397 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of nematode infections in cattle with an indwelling rumino-reticular ivermectin sustained release bolus. Egerton JR; Suhayda D; Eary CH Vet Parasitol; 1986 Nov; 22(1-2):67-75. PubMed ID: 3788027 [TBL] [Abstract][Full Text] [Related]
12. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications. Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of early-season prophylaxis using ivermectin with lungworm vaccination in the control of parasitic bronchitis and gastroenteritis in cattle. Jacobs DE; Foster J; Gowling G; Pilkington JG; Fox MT; Ryan WG Vet Parasitol; 1989 Nov; 34(1-2):45-56. PubMed ID: 2531489 [TBL] [Abstract][Full Text] [Related]
14. The American College of Surgeons Response to the COVID-19 Pandemic (Part II) : Advocacy and Public Policy. Wexner SD; Opelka F; Bailey PV; Cortés-Guiral D Am Surg; 2020 Jul; 86(7):757-761. PubMed ID: 32916074 [TBL] [Abstract][Full Text] [Related]
16. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Jans DA; Wagstaff KM Cells; 2020 Sep; 9(9):. PubMed ID: 32942671 [TBL] [Abstract][Full Text] [Related]
17. Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report. Ngwasiri CA; Abanda MH; Aminde LN J Med Case Rep; 2018 Sep; 12(1):254. PubMed ID: 30201032 [TBL] [Abstract][Full Text] [Related]
18. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591 [TBL] [Abstract][Full Text] [Related]
19. Are We Ready For The Next Pandemic? Torbay R Health Aff (Millwood); 2020 Jun; 39(6):1104. PubMed ID: 32479216 [No Abstract] [Full Text] [Related]
20. Defining COVID-19 as a Disaster Helps Guide Public Mental Health Policy. Alkhayyat A; Pankhania K Disaster Med Public Health Prep; 2020 Aug; 14(4):e44-e45. PubMed ID: 32782058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]